Terlipressin use in HRS-AKI and respiratory failure
- PMID: 39073583
- DOI: 10.1007/s00134-024-07556-8
Terlipressin use in HRS-AKI and respiratory failure
References
-
- Nadim MK, Forni LG, Ostermann M, on behalf of the ADQI 29/ICA Expert Panel (2024) Hepatorenal syndrome in the intensive care unit. Intensive Care Med. https://doi.org/10.1007/s00134-024-07438-z - DOI - PubMed - PMC
-
- Wong F, Pappas SC, Curry MP et al (2021) Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. N Engl J Med 384:818–828. https://doi.org/10.1056/NEJMoa2008290 - DOI - PubMed
-
- Wong F, Pappas SC, Reddy KR et al (2022) Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther 56:1284–1293. https://doi.org/10.1111/apt.17195 - DOI - PubMed - PMC
-
- Cavallin M, Piano S, Romano A et al (2016) Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study. Hepatology 63:983–992. https://doi.org/10.1002/hep.28396 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
